DOGLIONI, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 11.099
EU - Europa 10.970
NA - Nord America 10.722
SA - Sud America 2.828
Continente sconosciuto - Info sul continente non disponibili 415
AF - Africa 234
OC - Oceania 39
Totale 36.307
Nazione #
US - Stati Uniti d'America 10.083
RU - Federazione Russa 6.128
SG - Singapore 3.888
CN - Cina 3.476
BR - Brasile 2.298
IT - Italia 1.445
HK - Hong Kong 1.408
SE - Svezia 1.212
VN - Vietnam 1.007
FR - Francia 533
DE - Germania 420
BD - Bangladesh 304
GB - Regno Unito 295
CA - Canada 283
IN - India 232
FI - Finlandia 222
AR - Argentina 201
NL - Olanda 146
MX - Messico 124
ID - Indonesia 117
AT - Austria 111
JP - Giappone 105
EC - Ecuador 97
ES - Italia 92
PL - Polonia 90
TR - Turchia 90
ZA - Sudafrica 81
IQ - Iraq 76
IE - Irlanda 72
CO - Colombia 58
JM - Giamaica 48
PY - Paraguay 43
VE - Venezuela 43
SA - Arabia Saudita 42
CL - Cile 37
MY - Malesia 34
MA - Marocco 32
PK - Pakistan 31
CR - Costa Rica 30
UZ - Uzbekistan 30
AU - Australia 29
CH - Svizzera 28
PH - Filippine 28
UA - Ucraina 26
KE - Kenya 24
EG - Egitto 23
HN - Honduras 23
KR - Corea 23
TT - Trinidad e Tobago 22
LT - Lituania 21
PE - Perù 21
TN - Tunisia 21
AE - Emirati Arabi Uniti 19
NP - Nepal 19
JO - Giordania 18
UY - Uruguay 18
GT - Guatemala 17
IL - Israele 15
NI - Nicaragua 15
AZ - Azerbaigian 14
DZ - Algeria 14
TW - Taiwan 14
DO - Repubblica Dominicana 13
TH - Thailandia 13
BE - Belgio 12
PA - Panama 12
PS - Palestinian Territory 12
KZ - Kazakistan 11
HU - Ungheria 10
SV - El Salvador 10
BO - Bolivia 9
CZ - Repubblica Ceca 9
IR - Iran 9
LB - Libano 9
NO - Norvegia 9
PR - Porto Rico 9
BB - Barbados 8
BG - Bulgaria 8
ET - Etiopia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
OM - Oman 8
PT - Portogallo 8
BY - Bielorussia 7
CY - Cipro 7
NG - Nigeria 7
RO - Romania 7
AL - Albania 6
BZ - Belize 6
GE - Georgia 6
LV - Lettonia 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
BS - Bahamas 5
CI - Costa d'Avorio 5
GG - Guernsey 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
Totale 35.817
Città #
Singapore 1.705
Hong Kong 1.391
Dallas 1.374
Moscow 1.273
San Jose 1.181
Ashburn 1.122
Shanghai 629
Council Bluffs 539
Hefei 486
Beijing 451
Lauterbourg 422
Princeton 408
Lawrence 406
Ho Chi Minh City 388
Milan 379
New York 352
Los Angeles 268
Santa Clara 255
São Paulo 218
Hanoi 209
Phoenix 171
Nuremberg 127
Helsinki 120
Boardman 116
Rome 104
Munich 93
Brooklyn 91
Orem 84
Atlanta 77
Rio de Janeiro 74
Tokyo 73
Dublin 71
Chennai 68
Turku 65
London 63
Montreal 63
Warsaw 63
Denver 62
Toronto 60
Chicago 59
Haiphong 54
Vienna 53
Stockholm 52
Houston 51
Belo Horizonte 50
Frankfurt am Main 50
Seattle 50
Poplar 49
The Dalles 49
Boston 45
Guangzhou 44
Mexico City 43
Washington 42
Da Nang 41
Johannesburg 41
Brasília 40
Bologna 37
Manchester 37
Porto Alegre 36
San Francisco 36
Guayaquil 35
Pune 35
Amsterdam 33
Tianjin 33
Ankara 32
Columbus 32
Mumbai 32
Dhaka 30
Naples 29
Tashkent 29
Miami 27
Philadelphia 27
Quito 27
Baghdad 26
Buffalo 26
Curitiba 26
Hangzhou 26
Kingston 26
Shenzhen 26
Biên Hòa 25
Goiânia 25
Hải Dương 25
Jakarta 24
Lappeenranta 24
Salvador 24
Turin 24
Asunción 23
Cesano Boscone 23
Cleveland 23
San José 23
Campinas 22
Nairobi 22
Falkenstein 20
Paris 20
Kuala Lumpur 19
Querétaro 19
Caxias do Sul 18
Charlotte 18
Istanbul 18
Las Vegas 18
Totale 17.074
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 408
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 267
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 217
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 211
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 207
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 192
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 189
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 188
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 184
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 184
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 183
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 176
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 174
Influenza A Viruses Grow in Human Pancreatic Cells and Cause Pancreatitis and Diabetes in an Animal Model 171
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 169
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 168
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). 162
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 160
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 155
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 155
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 147
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 145
A multicenter randomized trial comparing a 25-gauge EUS fine-needle aspiration device with a 20-gauge EUS fine-needle biopsy device 145
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness 142
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 142
A multimodality test to guide the management of patients with a pancreatic cyst 141
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 139
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 137
A preoperative score to predict early death after pancreatic cancer resection 137
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 135
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 134
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 134
Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development 133
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 131
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 128
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 126
Liprin-alpha 1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation 126
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 125
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 124
Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function 124
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 124
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 124
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 123
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 123
24-hydroxycholesterol participates in pancreatic neuroendocrine tumor development 123
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma 122
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 121
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 121
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma 120
A Novel Histiocytosis With Synovial and Skin Involvement 120
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 120
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 119
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 117
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 116
A prognostic score to predict major complications after pancreaticoduodenectomy 116
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients 114
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 112
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 112
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 112
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation 112
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 112
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 111
Parenchymal biopsy in the management of patients with renal cancer 111
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 111
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 111
DNA methylation alterations in prostate cancer: from diagnosis to treatment 110
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 110
A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. 110
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 110
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 109
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 109
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 108
A woman and her canary: a tale of chlamydiae and lymphomas 108
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 108
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 108
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 107
Comparison of capillary versus aspiration technique in endoscopic ultrasound-guided fine-needle aspiration: A preliminary report 107
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 106
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 105
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 105
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 104
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 104
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 104
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 104
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 103
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 102
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 101
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 101
Mucin expression pattern in pancreatic diseases: Findings from EUS-guided fine-needle aspiration biopsies 101
Mesothelial or monocytic incidental cardiac excrescence on anterior leaflet of mitral valve 101
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 101
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 100
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 99
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 99
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 98
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. 98
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients 97
Establishment of a Transplantation Model of PDAC-Derived Liver Metastases 97
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 96
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 95
Totale 13.167
Categoria #
all - tutte 224.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 0 0 101 16 13 22 19 13 12 3 22
2022/20232.298 912 496 136 24 25 266 97 169 84 23 21 45
2023/20241.627 77 106 165 157 137 262 65 152 37 74 125 270
2024/20256.761 798 140 152 220 214 530 849 614 1.247 943 476 578
2025/202621.639 1.515 1.763 1.770 3.101 1.557 646 1.722 1.482 5.587 1.145 607 744
2026/20273.566 802 1.498 1.147 119 0 0 0 0 0 0 0 0
Totale 36.307